180 related articles for article (PubMed ID: 37599366)
1. Pancancer network analysis reveals key master regulators for cancer invasiveness.
Jethalia M; Jani SP; Ceccarelli M; Mall R
J Transl Med; 2023 Aug; 21(1):558. PubMed ID: 37599366
[TBL] [Abstract][Full Text] [Related]
2. Network-based identification of key master regulators associated with an immune-silent cancer phenotype.
Mall R; Saad M; Roelands J; Rinchai D; Kunji K; Almeer H; Hendrickx W; M Marincola F; Ceccarelli M; Bedognetti D
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33979427
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics characterization and validation of invasiveness-related molecular features across multiple cancer types.
Bi G; Liang J; Zheng Y; Li R; Zhao M; Huang Y; Zhan C; Xu S; Fan H
J Transl Med; 2021 Mar; 19(1):124. PubMed ID: 33766047
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
5. TOP2A and CENPF are synergistic master regulators activated in cervical cancer.
Yu B; Chen L; Zhang W; Li Y; Zhang Y; Gao Y; Teng X; Zou L; Wang Q; Jia H; Liu X; Zheng H; Hou P; Yu H; Sun Y; Zhang Z; Zhang P; Zhang L
BMC Med Genomics; 2020 Oct; 13(1):145. PubMed ID: 33023625
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
[TBL] [Abstract][Full Text] [Related]
7. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.
Remo A; Simeone I; Pancione M; Parcesepe P; Finetti P; Cerulo L; Bensmail H; Birnbaum D; Van Laere SJ; Colantuoni V; Bonetti F; Bertucci F; Manfrin E; Ceccarelli M
J Transl Med; 2015 May; 13():138. PubMed ID: 25928084
[TBL] [Abstract][Full Text] [Related]
8. Enhanced immortalization,
Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
Gene X; 2020 Dec; 5():100030. PubMed ID: 32550556
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a m
Zhao X; Cui L
Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
[TBL] [Abstract][Full Text] [Related]
10. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
11. HIF1A expression correlates with increased tumor immune and stromal signatures and aggressive phenotypes in human cancers.
Chen B; Li L; Li M; Wang X
Cell Oncol (Dordr); 2020 Oct; 43(5):877-888. PubMed ID: 32488852
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma.
Yang B; Fan Y; Chen M; Tang L; Tang X; Li H; Gu A; Liang R; Wu Y
Exp Eye Res; 2023 May; 230():109448. PubMed ID: 36967081
[TBL] [Abstract][Full Text] [Related]
14. Identification of Master Regulators Driving Disease Progression, Relapse, and Drug Resistance in Lung Adenocarcinoma.
Xu Q; Cha Q; Qin H; Liu B; Wu X; Shi J
Front Bioinform; 2022; 2():813960. PubMed ID: 36304306
[No Abstract] [Full Text] [Related]
15. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.
Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P
J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521
[TBL] [Abstract][Full Text] [Related]
16. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
17. Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses.
Sun S; Wang Y; Wang J; Bi J
J Transl Med; 2021 Sep; 19(1):409. PubMed ID: 34579753
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer.
Pan H; Pan J; Wu J
Front Immunol; 2022; 13():934221. PubMed ID: 35967425
[TBL] [Abstract][Full Text] [Related]
19. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
[TBL] [Abstract][Full Text] [Related]
20. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
Chang WH; Lai AG
BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
